Danielle Antalffy
Stock Analyst at UBS
(3.23)
# 2,366
Out of 4,349 analysts
603
Total ratings
50.1%
Success rate
1.8%
Average return
Main Sectors:
Stocks Rated by Danielle Antalffy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterated: Buy | $158 → $135 | $86.30 | +56.43% | 38 | Apr 20, 2026 | |
| BSX Boston Scientific | Rated: Buy | $120 → $105 | $49.11 | +113.81% | 42 | Mar 17, 2026 | |
| ISRG Intuitive Surgical | Rated: Hold | $570 → $550 | $423.63 | +29.83% | 10 | Mar 17, 2026 | |
| JNJ Johnson & Johnson | Rated: Buy | $214 → $280 | $230.80 | +21.32% | 34 | Mar 17, 2026 | |
| SYK Stryker | Rated: Hold | $400 → $380 | $307.63 | +23.53% | 20 | Mar 17, 2026 | |
| SGHT Sight Sciences | Rated: Buy | $12 → $11 | $5.06 | +117.39% | 6 | Mar 6, 2026 | |
| TMCI Treace Medical Concepts | Maintained: Hold | $2.5 → $2.25 | $3.08 | -26.95% | 15 | Mar 2, 2026 | |
| PRCT PROCEPT BioRobotics | Maintained: Buy | $62 → $30 | $27.20 | +10.29% | 9 | Mar 2, 2026 | |
| RXST RxSight | Maintained: Hold | $8 → $9 | $5.59 | +61.00% | 11 | Feb 26, 2026 | |
| TNDM Tandem Diabetes Care | Maintained: Hold | $17 → $22 | $16.72 | +31.58% | 27 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 | $142.65 | +180.41% | 43 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $55 | $28.09 | +95.80% | 26 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $12.10 | +98.35% | 2 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $104 | $75.57 | +37.62% | 40 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $19 | $19.25 | -1.30% | 26 | Feb 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $72.34 | +31.32% | 40 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $89 → $67 | $43.07 | +55.56% | 21 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $94 → $90 | $85.96 | +4.70% | 42 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $86 → $89 | $82.82 | +7.46% | 18 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $18.33 | +30.93% | 1 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 → $150 | $106.52 | +40.82% | 4 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $57 → $50 | $23.04 | +117.01% | 3 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $16 | $14.05 | +13.88% | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $2.25 | $4.61 | n/a | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $99.62 | n/a | 10 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $17.39 | n/a | 11 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $2.62 | n/a | 6 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $5.98 | n/a | 5 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $275 | $148.41 | n/a | 6 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 → $55 | $5.01 | n/a | 10 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $34.24 | n/a | 14 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $14 | $40.42 | n/a | 6 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $5 | $0.4958 | n/a | 14 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.54 | n/a | 20 | Jan 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $3 | $6.72 | n/a | 14 | Aug 9, 2021 |
Abbott Laboratories
Apr 20, 2026
Reiterated: Buy
Price Target: $158 → $135
Current: $86.30
Upside: +56.43%
Boston Scientific
Mar 17, 2026
Rated: Buy
Price Target: $120 → $105
Current: $49.11
Upside: +113.81%
Intuitive Surgical
Mar 17, 2026
Rated: Hold
Price Target: $570 → $550
Current: $423.63
Upside: +29.83%
Johnson & Johnson
Mar 17, 2026
Rated: Buy
Price Target: $214 → $280
Current: $230.80
Upside: +21.32%
Stryker
Mar 17, 2026
Rated: Hold
Price Target: $400 → $380
Current: $307.63
Upside: +23.53%
Sight Sciences
Mar 6, 2026
Rated: Buy
Price Target: $12 → $11
Current: $5.06
Upside: +117.39%
Treace Medical Concepts
Mar 2, 2026
Maintained: Hold
Price Target: $2.5 → $2.25
Current: $3.08
Upside: -26.95%
PROCEPT BioRobotics
Mar 2, 2026
Maintained: Buy
Price Target: $62 → $30
Current: $27.20
Upside: +10.29%
RxSight
Feb 26, 2026
Maintained: Hold
Price Target: $8 → $9
Current: $5.59
Upside: +61.00%
Tandem Diabetes Care
Feb 20, 2026
Maintained: Hold
Price Target: $17 → $22
Current: $16.72
Upside: +31.58%
Feb 19, 2026
Reiterated: Buy
Price Target: $400
Current: $142.65
Upside: +180.41%
Feb 18, 2026
Maintained: Buy
Price Target: $58 → $55
Current: $28.09
Upside: +95.80%
Feb 18, 2026
Reiterated: Buy
Price Target: $24
Current: $12.10
Upside: +98.35%
Feb 17, 2026
Maintained: Hold
Price Target: $104
Current: $75.57
Upside: +37.62%
Feb 16, 2026
Maintained: Hold
Price Target: $21 → $19
Current: $19.25
Upside: -1.30%
Feb 13, 2026
Reiterated: Buy
Price Target: $95
Current: $72.34
Upside: +31.32%
Feb 13, 2026
Maintained: Hold
Price Target: $89 → $67
Current: $43.07
Upside: +55.56%
Feb 12, 2026
Maintained: Hold
Price Target: $94 → $90
Current: $85.96
Upside: +4.70%
Feb 11, 2026
Maintained: Sell
Price Target: $86 → $89
Current: $82.82
Upside: +7.46%
Feb 9, 2026
Initiated Coverage: Buy
Price Target: $24
Current: $18.33
Upside: +30.93%
Jan 28, 2026
Maintained: Buy
Price Target: $145 → $150
Current: $106.52
Upside: +40.82%
Jan 5, 2026
Maintained: Buy
Price Target: $57 → $50
Current: $23.04
Upside: +117.01%
Nov 6, 2025
Maintained: Hold
Price Target: $16 → $16
Current: $14.05
Upside: +13.88%
Mar 28, 2023
Initiated Coverage: Hold
Price Target: $2.25
Current: $4.61
Upside: n/a
May 17, 2022
Reiterated: Buy
Price Target: $100
Current: $99.62
Upside: n/a
May 12, 2022
Maintained: Buy
Price Target: $12
Current: $17.39
Upside: n/a
May 10, 2022
Maintained: Buy
Price Target: $13
Current: $2.62
Upside: n/a
May 9, 2022
Maintained: Buy
Price Target: $12
Current: $5.98
Upside: n/a
May 5, 2022
Rated: Hold
Price Target: $275
Current: $148.41
Upside: n/a
May 5, 2022
Rated: Buy
Price Target: $65 → $55
Current: $5.01
Upside: n/a
May 4, 2022
Reiterated: Buy
Price Target: $45
Current: $34.24
Upside: n/a
May 4, 2022
Reiterated: Buy
Price Target: $12 → $14
Current: $40.42
Upside: n/a
May 3, 2022
Rated: Buy
Price Target: $5
Current: $0.4958
Upside: n/a
Jan 10, 2022
Maintained: Hold
Price Target: n/a
Current: $6.54
Upside: n/a
Aug 9, 2021
Reiterated: Hold
Price Target: $2 → $3
Current: $6.72
Upside: n/a